Phio Pharmaceuticals Corp.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Jun 9, 2023 PROXY CARD
DEF 14A Jun 9, 2023 DEFINITIVE PROXY STATEMENT
S-1 Jun 8, 2023 REGISTRATION STATEMENT
8-K Jun 2, 2023 FORM 8-K
424B5 Jun 1, 2023 424B5
8-K May 24, 2023 CURRENT REPORT
8-K May 16, 2023 CURRENT REPORT
8-K May 11, 2023 FORM 8-K
10-Q May 11, 2023 FORM 10-Q
424B3 May 10, 2023 PROSPECTUS
EFFECT May 9, 2023
CORRESP May 5, 2023
UPLOAD May 5, 2023
D May 2, 2023
S-1 Apr 28, 2023 S-1
8-K Apr 20, 2023 FORM 8-K
424B3 Apr 20, 2023 PROSPECTUS SUPPLEMENT
424B3 Apr 20, 2023 FORM 424(B)(3)
424B3 Apr 20, 2023 424(B)(3)
424B3 Apr 20, 2023 FORM 424(B)(3)
424B3 Apr 20, 2023 FORM 424(B)(3)
424B3 Apr 20, 2023 FORM 424(B)(3)
8-K Apr 20, 2023 CURRENT REPORT
424B5 Apr 19, 2023 FORM 424(B)(5)
8-K Apr 18, 2023 CURRENT REPORT
← Newer Page 9 of 36 · 884 filings Older →